Delivery Order SPE2DB24D2010-SPE2DB25FZUA7
Award Date
12/30/24
Potential Completion Date
12/31/24
Potential Value
$26K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,251.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a completion date of July 31, 2024. This is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $8,804.46, is for the provision of the pharmaceutical product PULMOZYME 1 MG/ML AMPUL 2.5ML. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential total value of $999,999,999.00 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,428.28, is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a specialty medication. The contract has a firm fixed-price pricing type and an ultimate completion date of August 21, 2024. This order is not designated as a set-aside contract. Amerisourcebergen Drug Corp, through its Corporate Office division, has been...
This federal contract award is a $30,700.72 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a completion date of January 17, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is a prime contractor that has received numerous federal contracts from DLA to...
This federal contract award, valued at $8,371.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the product "PULMOZYME 1 MG/ML AMPUL 2.5ML" and has a firm fixed-price pricing type with an ultimate completion date of December 19, 2024.
The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order valued at $2,540.23, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a completion date of February 9, 2024. The contract type is firm fixed price.
Amerisourcebergen Drug Corp is an established prime contractor providing a wide range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,167.20 firm fixed-price delivery order is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product, with a completion date of January 6, 2025.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
The federal contract award, identified as SPE2DX15D1053|SPE2DX25F6CYL, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,127.11 delivery order contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of November 7, 2024. The contract is not...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a specialty pharmaceutical product, with a potential value of $7,232.97. The contract has a performance period through January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations...
This federal contract award is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,122.56 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 14, 2024. This award is not designated as a set-aside contract....